These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 1811371)
61. Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo. Crowe JE; Gilmour PS; Murphy BR; Chanock RM; Duan L; Pomerantz RJ; Pilkington GR J Infect Dis; 1998 Apr; 177(4):1073-6. PubMed ID: 9534985 [TBL] [Abstract][Full Text] [Related]
62. Comparison of the ability of formalin-inactivated respiratory syncytial virus, immunopurified F, G and N proteins and cell lysate to enhance pulmonary changes in Balb/c mice. Vaux-Peretz F; Chapsal JM; Meignier B Vaccine; 1992; 10(2):113-8. PubMed ID: 1539464 [TBL] [Abstract][Full Text] [Related]
63. Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage. Anderson K; Stott EJ; Wertz GW J Gen Virol; 1992 May; 73 ( Pt 5)():1177-88. PubMed ID: 1375280 [TBL] [Abstract][Full Text] [Related]
64. A single nucleotide substitution in the transcription start signal of the M2 gene of respiratory syncytial virus vaccine candidate cpts248/404 is the major determinant of the temperature-sensitive and attenuation phenotypes. Whitehead SS; Firestone CY; Collins PL; Murphy BR Virology; 1998 Aug; 247(2):232-9. PubMed ID: 9705916 [TBL] [Abstract][Full Text] [Related]
65. Exogenous, TAP-independent lysosomal presentation of a respiratory syncytial virus CTL epitope. Johnstone C; Ramos M; García-Barreno B; López D; Melero JA; Del Val M Immunol Cell Biol; 2012 Nov; 90(10):978-82. PubMed ID: 22929180 [TBL] [Abstract][Full Text] [Related]
66. Cytotoxic T cell activity against the 22-kDa protein of human respiratory syncytial virus (RSV) is associated with a significant reduction in pulmonary RSV replication. Nicholas JA; Rubino KL; Levely ME; Meyer AL; Collins PL Virology; 1991 Jun; 182(2):664-72. PubMed ID: 2024493 [TBL] [Abstract][Full Text] [Related]
68. Protective epitopes on the fusion protein of respiratory syncytial virus recognized by murine and bovine monoclonal antibodies. Taylor G; Stott EJ; Furze J; Ford J; Sopp P J Gen Virol; 1992 Sep; 73 ( Pt 9)():2217-23. PubMed ID: 1383403 [TBL] [Abstract][Full Text] [Related]
69. Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection. Johnson TR; Graham BS Pediatr Infect Dis J; 2004 Jan; 23(1 Suppl):S46-57. PubMed ID: 14730270 [TBL] [Abstract][Full Text] [Related]
70. HIV-specific T lymphocyte immunity in mice immunized with a recombinant vaccinia virus. Michel F; Hoffenbach A; Langlade-Demoyen P; Guy B; Girard M; Lecocq JP; Wain-Hobson S; Kieny MP; Plata F Eur J Immunol; 1988 Dec; 18(12):1917-24. PubMed ID: 2905993 [TBL] [Abstract][Full Text] [Related]
71. Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats. Prince GA; Capiau C; Deschamps M; Fabry L; Garçon N; Gheysen D; Prieels JP; Thiry G; Van Opstal O; Porter DD J Virol; 2000 Nov; 74(22):10287-92. PubMed ID: 11044072 [TBL] [Abstract][Full Text] [Related]
72. Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment. Plotnicky-Gilquin H; Huss T; Aubry JP; Haeuw JF; Beck A; Bonnefoy JY; Nguyen TN; Power UF Virology; 1999 May; 258(1):128-40. PubMed ID: 10329575 [TBL] [Abstract][Full Text] [Related]
73. Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine. Trudel M; Nadon F; Séguin C; Brault S; Lusignan Y; Lemieux S Vaccine; 1992; 10(2):107-12. PubMed ID: 1539463 [TBL] [Abstract][Full Text] [Related]
77. Hydrophobicity engineering to facilitate surface display of heterologous gene products on Staphylococcus xylosus. Nguyen TN; Gourdon MH; Hansson M; Robert A; Samuelson P; Libon C; Andréoni C; Nygren PA; Binz H; Uhlén M J Biotechnol; 1995 Oct; 42(3):207-19. PubMed ID: 7576540 [TBL] [Abstract][Full Text] [Related]
78. Recognition of respiratory syncytial (RS) virus proteins by human and BALB/C CD4+ lymphocytes. Anderson JJ; Harrop JA; Peers H; Turnbull T; Toms GL; Scott R J Med Virol; 1991 Nov; 35(3):165-73. PubMed ID: 1839552 [TBL] [Abstract][Full Text] [Related]
79. Immunoregulatory role of secreted glycoprotein G from respiratory syncytial virus. Ray R; Hoft DF; Meyer K; Brown R; Lagging LM; Belshe RB Virus Res; 2001 Jun; 75(2):147-54. PubMed ID: 11325469 [TBL] [Abstract][Full Text] [Related]
80. The new generation of recombinant viral subunit vaccines. Ellis RW Curr Opin Biotechnol; 1996 Dec; 7(6):646-52. PubMed ID: 8939634 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]